Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Genotype-phenotype relationships as prognosticators in Rett syndrome should be handled with care in clinical practice.

Halbach NS, Smeets EE, van den Braak N, van Roozendaal KE, Blok RM, Schrander-Stumpel CT, Frijns JP, Maaskant MA, Curfs LM.

Am J Med Genet A. 2012 Feb;158A(2):340-50. doi: 10.1002/ajmg.a.34418. Epub 2011 Dec 21.

PMID:
22190343
2.

PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome.

Godschalk PC, van Belkum A, van den Braak N, van Netten D, Ang CW, Jacobs BC, Gilbert M, Endtz HP.

J Clin Microbiol. 2007 Jul;45(7):2316-20. Epub 2007 May 16.

3.

Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barré syndrome by high-throughput AFLP analysis.

Godschalk PC, Bergman MP, Gorkink RF, Simons G, van den Braak N, Lastovica AJ, Endtz HP, Verbrugh HA, van Belkum A.

BMC Microbiol. 2006 Apr 4;6:32.

4.

Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.

Godschalk PC, Gilbert M, Jacobs BC, Kramers T, Tio-Gillen AP, Ang CW, Van den Braak N, Li J, Verbrugh HA, Van Belkum A, Endtz HP.

Microbes Infect. 2006 Jan;8(1):248-53. Epub 2005 Sep 13.

PMID:
16213180
5.

A new high-throughput AFLP approach for identification of new genetic polymorphism in the genome of the clonal microorganism Mycobacterium tuberculosis.

van den Braak N, Simons G, Gorkink R, Reijans M, Eadie K, Kremers K, van Soolingen D, Savelkoul P, Verbrugh H, van Belkum A.

J Microbiol Methods. 2004 Jan;56(1):49-62.

PMID:
14706750
6.

Molecular evidence for dissemination of unique Campylobacter jejuni clones in Curaçao, Netherlands Antilles.

Duim B, Godschalk PC, van den Braak N, Dingle KE, Dijkstra JR, Leyde E, van der Plas J, Colles FM, Endtz HP, Wagenaar JA, Maiden MC, van Belkum A.

J Clin Microbiol. 2003 Dec;41(12):5593-7.

7.

Risk factors associated with Campylobacter jejuni infections in Curaçao, Netherlands Antilles.

Endtz HP, van West H, Godschalk PC, de Haan L, Halabi Y, van den Braak N, Kesztyüs BI, Leyde E, Ott A, Verkooyen R, Price LJ, Woodward DL, Rodgers FG, Ang CW, van Koningsveld R, van Belkum A, Gerstenbluth I.

J Clin Microbiol. 2003 Dec;41(12):5588-92.

8.

Clindamycin-resistant, toxin A-negative, toxin B-positive Clostridium difficile strains cause antibiotic-associated diarrhea among children hospitalized in a hematology unit.

Pituch H, vavn Belkum A, van den Braak N, Obuch-Woszczatyñski P, Sawicka-Grzelak A, Verbrugh H, Meisel-Mikołajczyk F, Luczak M.

Clin Microbiol Infect. 2003 Aug;9(8):903-4. No abstract available.

9.

Recent emergence of an epidemic clindamycin-resistant clone of Clostridium difficile among Polish patients with C. difficile-associated diarrhea.

Pituch H, Van Belkum A, Van Den Braak N, Obuch-Woszczatynski P, Verbrugh H, Meisel-Mikołajczyk F, uczak M.

J Clin Microbiol. 2003 Sep;41(9):4184-7.

10.

Identification of medically relevant microorganisms by vibrational spectroscopy.

Maquelin K, Kirschner C, Choo-Smith LP, van den Braak N, Endtz HP, Naumann D, Puppels GJ.

J Microbiol Methods. 2002 Nov;51(3):255-71. Review.

PMID:
12223286
11.

Variable flagella expression among clonal toxin A-/B+Clostridium difficile strains with highly homogeneous flagellin genes.

Pituch H, Obuch-Woszczatyñski P, van den Braak N, van Belkum A, Kujawa M, Luczak M, Meisel-Mikolajczyk F.

Clin Microbiol Infect. 2002 Mar;8(3):187-8. No abstract available.

12.

Characterization of Clostridium perfringens strains isolated from Polish patients with suspected antibiotic-associated diarrhea.

Pituch H, van den Braak N, van Belkum A, Van Leeuwen W, Obuch-Woszczatyński P, Łuczak M, Verbrugh H, Meisel-Mikołajczyk F, Martirosian G.

Med Sci Monit. 2002 Mar;8(3):BR85-8.

PMID:
11887023
13.

Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.

Ang CW, Laman JD, Willison HJ, Wagner ER, Endtz HP, De Klerk MA, Tio-Gillen AP, Van den Braak N, Jacobs BC, Van Doorn PA.

Infect Immun. 2002 Mar;70(3):1202-8.

14.

Isolation and identification of Campylobacter species by use of selective enrichment, nucleic acid amplification methods, and gene probes.

van Belkum A, van den Braak N, van Doorn LJ, Endtz H.

Methods Mol Biol. 2002;179:101-11. No abstract available.

PMID:
11692855
15.

Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland.

Pituch H, van den Braak N, van Leeuwen W, van Belkum A, Martirosian G, Obuch-Woszczatyński P, Łuczak M, Meisel-Mikołajczyk F.

Clin Microbiol Infect. 2001 Aug;7(8):442-6.

16.

Sequence typing confirms that Campylobacter jejuni strains associated with Guillain-Barré and Miller-Fisher syndromes are of diverse genetic lineage, serotype, and flagella type.

Dingle KE, Van Den Braak N, Colles FM, Price LJ, Woodward DL, Rodgers FG, Endtz HP, Van Belkum A, Maiden MC.

J Clin Microbiol. 2001 Sep;39(9):3346-9.

17.

A Campylobacter jejuni gene associated with immune-mediated neuropathy.

van Belkum A, van den Braak N, Godschalk P, Ang W, Jacobs B, Gilbert M, Wakarchuk W, Verbrugh H, Endtz H.

Nat Med. 2001 Jul;7(7):752-3. No abstract available.

PMID:
11433317
18.

In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia.

Livermore DM, Carter MW, Bagel S, Wiedemann B, Baquero F, Loza E, Endtz HP, van Den Braak N, Fernandes CJ, Fernandes L, Frimodt-Moller N, Rasmussen LS, Giamarellou H, Giamarellos-Bourboulis E, Jarlier V, Nguyen J, Nord CE, Struelens MJ, Nonhoff C, Turnidge J, Bell J, Zbinden R, Pfister S, Mixson L, Shungu DL.

Antimicrob Agents Chemother. 2001 Jun;45(6):1860-7.

19.

Dietary habits and gastrointestinal colonization by antibiotic resistant microorganisms.

van Den Braak N, van Belkum A, Kreft D, Verbrugh H, Endtz H.

J Antimicrob Chemother. 2001 Apr;47(4):498-500. No abstract available.

PMID:
11266432
20.

Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.

van Den Braak N, Goessens W, van Belkum A, Verbrugh HA, Endtz HP.

J Clin Microbiol. 2001 Jan;39(1):351-3.

21.

Evaluation of a new commercial immunoassay for rapid detection of Campylobacter jejuni in stool samples.

Endtz HP, Ang CW, van den Braak N, Luijendijk A, Jacobs BC, de Man P, van Duin JM, van Belkum A, Verbrugh HA.

Eur J Clin Microbiol Infect Dis. 2000 Oct;19(10):794-7.

PMID:
11117647
22.
23.

Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands.

van den Braak N, Ott A, van Belkum A, Kluytmans JA, Koeleman JG, Spanjaard L, Voss A, Weersink AJ, Vandenbroucke-Grauls CM, Buiting AG, Verbrugh HA, Endtz HP.

Infect Control Hosp Epidemiol. 2000 Aug;21(8):520-4.

PMID:
10968718
24.

Host specificity of vancomycin-resistant Enterococcus faecium.

Willems RJ, Top J, van Den Braak N, van Belkum A, Endtz H, Mevius D, Stobberingh E, van Den Bogaard A, van Embden JD.

J Infect Dis. 2000 Sep;182(3):816-23. Epub 2000 Aug 10.

PMID:
10950776
25.

Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.

Endtz HP, Ang CW, van Den Braak N, Duim B, Rigter A, Price LJ, Woodward DL, Rodgers FG, Johnson WM, Wagenaar JA, Jacobs BC, Verbrugh HA, van Belkum A.

J Clin Microbiol. 2000 Jun;38(6):2297-301.

26.

The prevalence and clonal expansion of high-level gentamicin-resistant enterococci isolated from blood cultures in a Dutch university hospital.

van Den Braak N, van Belkum A, Kreft D, te Witt R, Verbrugh HA, Endtz HP.

J Antimicrob Chemother. 1999 Dec;44(6):795-8.

PMID:
10590281
27.

Vancomycin resistance: status quo and quo vadis.

Endtz HP, van den Braak N, Verbrugh HA, van Belkum A.

Eur J Clin Microbiol Infect Dis. 1999 Oct;18(10):683-90. Review.

PMID:
10584893
28.

Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals.

Willems RJ, Top J, van den Braak N, van Belkum A, Mevius DJ, Hendriks G, van Santen-Verheuvel M, van Embden JD.

Antimicrob Agents Chemother. 1999 Mar;43(3):483-91.

29.

Glycopeptide resistance amongst Staphylococcus spp.

van den Braak N, van Belkum A, te Witt R, Verbrugh HA, Endtz HP.

J Antimicrob Chemother. 1998 Nov;42(5):673-5. No abstract available.

PMID:
9848458
30.

Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in The Netherlands.

van den Braak N, van Belkum A, van Keulen M, Vliegenthart J, Verbrugh HA, Endtz HP.

J Clin Microbiol. 1998 Jul;36(7):1927-32.

31.

Comparison of eight methods to detect vancomycin resistance in enterococci.

Endtz HP, Van Den Braak N, Van Belkum A, Goessens WH, Kreft D, Stroebel AB, Verbrugh HA.

J Clin Microbiol. 1998 Feb;36(2):592-4.

32.

Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands.

Endtz HP, van den Braak N, van Belkum A, Kluytmans JA, Koeleman JG, Spanjaard L, Voss A, Weersink AJ, Vandenbroucke-Grauls CM, Buiting AG, van Duin A, Verbrugh HA.

J Clin Microbiol. 1997 Dec;35(12):3026-31.

33.

Vancomycin-resistant enterococci in vegetarians.

van den Braak N, Kreft D, van Belkum A, Verbrugh H, Endtz H.

Lancet. 1997 Jul 12;350(9071):146-7. No abstract available.

PMID:
9228991
34.

In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis.

Mouton JW, Endtz HP, den Hollander JG, van den Braak N, Verbrugh HA.

J Antimicrob Chemother. 1997 May;39 Suppl A:75-80.

PMID:
9511068
35.
36.

Genetic homogeneity among methicillin-resistant Staphylococcus aureus strains from Saudi Arabia.

Van Belkum A, Vandenbergh M, Kessie G, Qadri SM, Lee G, van den Braak N, Verbrugh H, al-Ahdal MN.

Microb Drug Resist. 1997 Winter;3(4):365-9.

PMID:
9442489
37.

Genotypic diversity of Campylobacter lari isolated from mussels and oysters in The Netherlands.

Endtz HP, Vliegenthart JS, Vandamme P, Weverink HW, van den Braak NP, Verbrugh HA, van Belkum A.

Int J Food Microbiol. 1997 Jan;34(1):79-88.

PMID:
9029257
38.

Vancomycin-resistant enterococci in cats and dogs.

van Belkun A, van den Braak N, Thomassen R, Verbrugh H, Endtz H.

Lancet. 1996 Oct 12;348(9033):1038-9. No abstract available.

PMID:
8855893

Supplemental Content

Loading ...
Support Center